Source document

Loading document…
KPIsSections13
Headline metrics
RevenueGREEN$933.3M
Net incomeGREEN-$50.0M
Net marginGREEN-5.4%
Operating marginGREEN1.9%
Red flags1 red
Liquidity1
RED
Net margin -5.4%net_margin_sharply_negative
Net income margin below -5% — profitability materially negative vs revenue.
Income Statement
Income Statement
MetricValueFlag
Revenue$933.3MGREEN
Operating Margin1.9%GREEN
Net Margin-5.4%GREEN
Operating Income$17.6MGREEN
Net Income-$50.0MGREEN
EBITDA$77.9MGREEN
Income Tax Expense$29.6MGREEN
Pre-tax Income-$20.4MGREEN
EPS Diluted€-0.09GREEN
Interest Expense$993,000GREEN
Net Interest Exp-$993,000GREEN
Income/(Loss) from Affiliates$2.3MGREEN
Basic EPS-$0.085GREEN
Balance Sheet
Balance Sheet
MetricValueFlag
Total Assets$1.19BGREEN
Current Assets$406.2MGREEN
Current Liabilities$232.6MGREEN
Total Liabilities$263.3MGREEN
Total Equity$923.6MGREEN
Noncontrolling Interest$73,000GREEN
Retained Earnings$3.43BGREEN
Cash & Equivalents$105.9MGREEN
Trade Receivables$39.8MGREEN
Trade Payables$55.8MGREEN
Inventory$192.5MGREEN
Prepaid Expenses$24.6MGREEN
Gross Property, Plant & Equipment$723.9MGREEN
Total Intangibles$5.6MGREEN
Other Long-Term Assets$32.5MGREEN
Current Portion of Capital Leases$4.7MGREEN
Capital Leases$419,000GREEN
Common Stock$121.6MGREEN
Additional Paid In Capital$185.1MGREEN
Comprehensive Income and Other-$2.81BGREEN
Cash Flow
Cash Flow
MetricValueFlag
Operating Cash Flow$91.9MGREEN
Investing Cash Flow-$97.5MGREEN
Depreciation & Amortization$60.3MGREEN
Free Cash Flow-$5.6MGREEN
Financing Cash Flow-$5.7MGREEN
Net Income (starting point for CFO)$66.8MGREEN
Asset Writedown & Restructuring Costs$611,000GREEN
Change in Inventories-$10.9MGREEN
Change in Income Taxes$23.3MGREEN
Common Dividends Paid$46,000GREEN
Foreign Exchange Rate Effect$2.0MGREEN
Cash Interest Paid$815,000GREEN

Sections in this filing

Financial Statements

The consolidated financial statements of Ferrexpo plc and its subsidiaries have been prepared in accordance with International Financial Reporting The financial statements were approved by the Board of Directors and authorised for issue on 18 March 2025 and signed on behalf of the Board.